Cargando…

Characterization of Glioblastoma Cells Response to Regorafenib

SIMPLE SUMMARY: Glioblastoma is the most aggressive primary brain tumor, characterized by a short survival and by an invariably poor outcome. The clinical management of glioblastoma patients is based on surgery followed by adjuvant radio-chemotherapy. Glioblastoma therapy remained substantially unal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mongiardi, Maria Patrizia, Buccarelli, Mariachiara, Formato, Alessia, Orecchini, Elisa, Salbini, Maria, Ricci, Valentina, Orsini, Tiziana, Putti, Sabrina, Chiesa, Silvia, Ricci-Vitiani, Lucia, D’Alessandris, Quintino Giorgio, Pallini, Roberto, Levi, Andrea, Falchetti, Maria Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777191/ https://www.ncbi.nlm.nih.gov/pubmed/36551679 http://dx.doi.org/10.3390/cancers14246193

Ejemplares similares

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
por: Pacioni, Simone, et al.
Publicado: (2017)

Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
por: Falchetti, Maria Laura, et al.
Publicado: (2018)

Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood–Brain Barrier
por: Pacioni, Simone, et al.
Publicado: (2019)

Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022)

Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments
por: Grande, Sveva, et al.
Publicado: (2022)

Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an In Vivo Assay of Early Tumor Angiogenesis
por: D'Alessandris, Quintino Giorgio, et al.
Publicado: (2021)

A three‐microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes
por: Marziali, Giovanna, et al.
Publicado: (2017)

Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
por: Buccarelli, Mariachiara, et al.
Publicado: (2018)

Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study
por: Palma, Alessandra, et al.
Publicado: (2021)

Short tandem repeat profiling for the authentication of cancer stem‐like cells
por: Visconti, Paola, et al.
Publicado: (2020)

FMRP modulates the Wnt signalling pathway in glioblastoma
por: Pedini, Giorgia, et al.
Publicado: (2022)

Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth
por: Buccarelli, Mariachiara, et al.
Publicado: (2021)

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
por: Martini, Maurizio, et al.
Publicado: (2018)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
por: Papale, Marco, et al.
Publicado: (2020)

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
por: Marziali, G., et al.
Publicado: (2016)

Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
por: Chiesa, Silvia, et al.
Publicado: (2022)

Deregulated expression of the imprinted DLK1-DIO3 region in glioblastoma stemlike cells: tumor suppressor role of lncRNA MEG3
por: Buccarelli, Mariachiara, et al.
Publicado: (2020)

Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
por: Sighel, Denise, et al.
Publicado: (2021)

Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016)

Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2021)

Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
por: Cesarini, Valeriana, et al.
Publicado: (2017)

Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like Cells
por: Dini, Valentina, et al.
Publicado: (2023)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts
por: Pacioni, Simone, et al.
Publicado: (2015)

Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1
por: Lulli, Valentina, et al.
Publicado: (2020)

Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model
por: Merolle, Matilde, et al.
Publicado: (2020)

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal
por: Lulli, Valentina, et al.
Publicado: (2015)

Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs
por: Grande, Sveva, et al.
Publicado: (2018)

5-Aminolevulinic Acid (5-ALA)-Induced Protoporphyrin IX Fluorescence by Glioma Cells—A Fluorescence Microscopy Clinical Study
por: Pacioni, Simone, et al.
Publicado: (2022)

G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells
por: Berardinelli, F., et al.
Publicado: (2019)

Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells
por: Ziberi, Sihana, et al.
Publicado: (2019)

c-MYC inhibition impairs hypoxia response in glioblastoma multiforme
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2016)

TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients
por: Morelli, Maria Beatrice, et al.
Publicado: (2022)

Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions
por: Palma, Alessandra, et al.
Publicado: (2020)

A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology
por: Tate, Courtney M., et al.
Publicado: (2015)

Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2015)

Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration
por: Di Giuseppe, Fabrizio, et al.
Publicado: (2021)

Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
por: Esposito, Carla Lucia, et al.
Publicado: (2020)

Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments
por: Iannolo, Gioacchin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q6vt8mkrt7auk5ad4s47btpvh5